# 510(k) Summary - Elecsys TSH CalSet

# Introduction

According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence

# Submitter name, address, contact

Roche Diagnostics 9115 Hague Rd Indianapolis IN 46250 (317) 521-3544

Contact person: Kay A. Taylor

Date prepared: March 17, 2006

# Device Name

Proprietary name: Elecsys TSH CalSet

Common name: Calibrator

Classification name: Calibrator, Secondary

# Device description

The Elecsys TSH CalSet consists of equine serum matrix (Cal 1) and a human serum matrix with human TSH (Cal 2) in two concentration ranges. The Elccsys TSH CalSet is supplied in ready for use liquid format.

# 510(k) Summary - Elecsys® TSH CalSet, continued

# Intended use

Elecsys TSH CalSet is used for calibrating the quantitative Elecsys TSH assay on the Elecsys immunoassay analyzers.

# Predicate Device

The Elecsys TSH CalSet is equivalent to other devices legally marketed in the United States. We claim equivalence to the Elecsys TSH CalSet (K961491).

# Device Comparison

The table below compares the device features of the Elecsys TSH CalSet (modified) and original (K961491).

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=1>Elecsys TSH CalSet(K961491)</td><td rowspan=1 colspan=1>Elecsys TSH CalSet(Modified Device)</td></tr><tr><td rowspan=1 colspan=1>Intended use</td><td rowspan=1 colspan=1>Used for calibrating the quantitativeElecsys TSH assay on the Elecsys2010 immunoassay analyzer.</td><td rowspan=1 colspan=1>Used for calibrating the quantitativeElecsys TSH assay on the Elecsysimmunoassay analyzers.</td></tr><tr><td rowspan=1 colspan=1>Traceability</td><td rowspan=1 colspan=1>Assay standardized against the 2&quot;d IRPWHO reference standard 80/558</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Two</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Storage Form</td><td rowspan=1 colspan=1>Liquid</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Horse serum matrix with addedrecombinant TSH</td><td rowspan=1 colspan=1>Equine serum matrix with added TSH(human).</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Unopened:at 2-8°C up to the statedexpiration date.Opened:0 4 weeks at at 2-8°CO on the analyzer up to a maximumof five hours in total.</td><td rowspan=1 colspan=1>Unopened:Oat 2-8°C up to the statedexpiration date.Opened:0 after opening in aliquots at 2-8°Cfor 12 weeks.0 on 1010/2010 at 20-25°C up to 5hours0 on E170 use only once.</td></tr><tr><td rowspan=1 colspan=1>TargetConcentrations</td><td rowspan=1 colspan=1>Cal 1: 0 μIU/mLCal 2: 1.5 μIU/mL</td><td rowspan=1 colspan=1>Same</td></tr></table>

Ms. Kay A. Taylor Regulatory Affairs Principal Roche Diagnostics Corp. 9115 Hague Road Indianapolis, IN 46250

Re: k060754 Trade/Device Name: Elecsys TSH CalSet Regulation Number: 21 CFR§862.1150 Regulation Name: Calibrator Regulatory Class: Class II Product Code: JIT Dated: March 17, 2006 Received: March 21, 2006

Dear Ms. Taylor:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmctic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or classIII (PMA). it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition. FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 ('FR Part 807): labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2 -

This letter will allow you to begin marketing your device as described in your Section 510(k) pe notfiiTh Afn usanal uvaen  yur devic aly marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

![](images/ef8b22397d23eed9ff523b3bb5b97b0e8a27802435b9511a5bbeac2f43c2e0fb.jpg)

Alberto Gutierrcz, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use

510(k) Number (if known): K060754

Device Name: Elecsys TSH CalSet

Indications For Use:

The Elecsys TSH CalSet is used for calibrating the quantitative Elecsys TSH assay on the Elecsys immunoassay analyzers.

Concurrence of CDRH, Offce of In Vitro Diagnostic Devices (OIVD) C. Jivision Sign-Off Page 1 of 1 10(k KOC0ZS7